Business | Published:

The chips are down

    Geneticists' desire to track the roots of complex diseases has shaken up the market for gene chips. Meredith Wadman reports on two firms jostling for position in a business potentially worth US$500 million.

    Access optionsAccess options

    Rent or Buy article

    Get time limited or full article access on ReadCube.


    All prices are NET prices.

    Related links

    Rights and permissions

    Reprints and Permissions

    About this article

    Further reading


    By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.